Cargando…

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

Defects in brain energy metabolism and proteopathic stress are implicated in age-related degenerative neuronopathies, exemplified by Alzheimer’s disease (AD) and Parkinson’s disease (PD). As the currently available drug regimens largely aim to mitigate cognitive decline and/or motor symptoms, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monti, Giulia, Gomes Moreira, Diana, Richner, Mette, Mutsaers, Henricus Antonius Maria, Ferreira, Nelson, Jan, Asad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265397/ https://www.ncbi.nlm.nih.gov/pubmed/35805109 http://dx.doi.org/10.3390/cells11132023

Ejemplares similares

The Neurovascular Unit in Glaucomatous Neurodegeneration
por: Wareham, Lauren K., et al.
Publicado: (2020)

Editorial: The Role of Neurovascular Unit in Neurodegeneration
por: Zhou, Zhi Dong, et al.
Publicado: (2022)

Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
por: Ghosh, Puja, et al.
Publicado: (2023)

A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
por: Gomes Moreira, Diana, et al.
Publicado: (2023)

Systemic Treatment with Erythropoietin Protects the Neurovascular Unit in a Rat Model of Retinal Neurodegeneration
por: Busch, Stephanie, et al.
Publicado: (2014)

The Contribution of Dysfunctional Chloride Channels to Neurovascular Deficiency and Neurodegeneration
por: Gascoigne, David A., et al.
Publicado: (2021)

Systemic GLP-1R agonist treatment reverses mouse glial and neurovascular cell transcriptomic aging signatures in a genome-wide manner
por: Li, Zhongqi, et al.
Publicado: (2021)

A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease
por: Poupon-Bejuit, L., et al.
Publicado: (2022)

Blood–Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration
por: Salmina, Alla B., et al.
Publicado: (2021)

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
por: Madsen, Mette Simone Aae, et al.
Publicado: (2019)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Persistent Neurovascular Unit Dysfunction: Pathophysiological Substrate and Trigger for Late-Onset Neurodegeneration After Traumatic Brain Injury
por: Zhou, Yunxiang, et al.
Publicado: (2020)

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
por: Gadgaard, Sarina, et al.
Publicado: (2022)

Tau induces PSD95-nNOS uncoupling and neurovascular dysfunction independent of neurodegeneration
por: Park, Laibaik, et al.
Publicado: (2020)

The Cardiovascular Effects of GLP-1 Receptor Agonists
por: Okerson, Theodore, et al.
Publicado: (2012)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Clinical Trial Highlights – GLP-1 agonists
por: McFarthing, Kevin, et al.
Publicado: (2020)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
por: Wang, Qinghua, et al.
Publicado: (2010)

Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension
por: Presa, Jessica L., et al.
Publicado: (2020)

Neurovascular Unit in Chronic Pain
por: Radu, Beatrice Mihaela, et al.
Publicado: (2013)

Oxidative Stress and the Neurovascular Unit
por: Rinaldi, Carmela, et al.
Publicado: (2021)

Pathology of the neurovascular unit in leukodystrophies
por: Zarekiani, Parand, et al.
Publicado: (2021)

Tight Junctions of the Neurovascular Unit
por: Hudson, Natalie, et al.
Publicado: (2021)

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
por: Willard, Francis S., et al.
Publicado: (2020)

The Protective Role of Microglial PPARα in Diabetic Retinal Neurodegeneration and Neurovascular Dysfunction
por: Yuan, Tian, et al.
Publicado: (2022)

Basal Insulin Use With GLP-1 Receptor Agonists
por: Anderson, Sarah L., et al.
Publicado: (2016)

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
por: Zhao, Xin, et al.
Publicado: (2021)

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond
por: Prasad-Reddy, Lalita, et al.
Publicado: (2015)

Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
por: Nelson, Amy R.
Publicado: (2022)

Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
por: Trapp, Stefan, et al.
Publicado: (2021)

Intracellular Sources of ROS/H(2)O(2) in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum
por: Konno, Tasuku, et al.
Publicado: (2021)

Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegeneration
por: Amato, Antonella, et al.
Publicado: (2019)

TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)

Innate Immunity Cells and the Neurovascular Unit
por: Presta, Ivan, et al.
Publicado: (2018)

Interaction of Microglia and Astrocytes in the Neurovascular Unit
por: Liu, Li-rong, et al.
Publicado: (2020)

Neurovascular Unit Dysfunction and Neurodegenerative Disorders
por: Yu, Xing, et al.
Publicado: (2020)

The Neurovascular Unit Dysfunction in Alzheimer’s Disease
por: Soto-Rojas, Luis O., et al.
Publicado: (2021)

Dysfunction of the neurovascular unit in brain aging
por: Liu, Shu, et al.
Publicado: (2023)

Dysfunction of the Neurovascular Unit by Psychostimulant Drugs
por: Vo, Tam Thuy Lu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_060a6fqbaf679vasqmhrl47dj1